Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease

Journal of Pharmacology and Experimental Therapeutics

Volumn 315, Issue 1, 2005, Pages 8-15

  Carbone, David L ^a   Doorn, Jonathan A ^b   Kiebler, Zachary ^a   Ickes, Brian R ^a   Petersen, Dennis R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ALCOHOL; ALDEHYDE; CHAPERONE; CYSTEINE; HEAT SHOCK PROTEIN; N ETHYLMALEIMIDE; THIOL;

ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; OXIDATIVE STRESS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; STATISTICAL SIGNIFICANCE; TANDEM MASS SPECTROMETRY;

ALDEHYDES; ANIMALS; DISEASE MODELS, ANIMAL; HSP90 HEAT-SHOCK PROTEINS; LIPID PEROXIDATION; LIVER DISEASES, ALCOHOLIC; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 25644451257     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.105.088088     Document Type: Article

References (36)

1. Alderton AL, Faustman C, Liebler DC, and Hill DW (2003) Induction of redox instability of bovine myoglobin by adduction with 4-hydroxy-2-nonenal. Biochemistry 42:4398-4405.
2. Beliakoff J and Whitesell L (2004) Hsp90: an emerging target for breast cancer therapy. Anticancer Drugs 14:651-662.
3. Bell DR and Poland A (2000) Binding of aryl hydrocarbon receptor (AhR) to AhRinteracting protein. The role of hsp90. J Biol Chem 275:36407-36414.
4. Borkovich KA, Farrelly FW, Finkelstein DB, Taulien J, and Lindquist S (1989) hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures. Mol Cell Biol 9:3919-3930.
5. Carbone DL, Doorn JA, Kiebler Z, Sampey BP, and Petersen DR (2004) Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem Res Toxicol 17:1459-1467.
6. Diehl AM (2001) Nonalcoholic fatty liver disease: implications for alcoholic liver disease. Alcohol Clin Exp Res 25:8S-14S.
7. Doorn JA and Petersen DR (2002) Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem Res Toxicol 15:1445-1450.
8. Esterbauer H, Schaur RJ, and Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 11:81-128.
9. Esterbauer H, Zollner H, and Schaur RJ (1989) Aldehydes formed by lipid peroxidation: mechanisms of formation, occurrence and determination, in Membrane Lipid Oxidation (Vigo-Pelfrey C ed) vol 1, pp 239-268, CRC Press, Boca Raton.
10. George P, Bali P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Fiskus W, Scuto A, Annavarapu S, et al. (2004) Cotreatment with 17-allylamino- demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human myelogenous leukemia cells with mutant FLT-3. Cancer Res 64:3645-3652.
11. Goasduff T and Cederbaum AI (2000) CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone Hsp90. Arch Biochem Biophys 379:321-330.
12. Hartley DP, Kolaja KL, Reichard J, and Petersen DR (1999) 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection an lobular localization. Toxicol Appl Pharmacol 161:23-33.
13. Hickey E, Brandon SE, Smale G, Lloyd D, and Weber LA (1989) Sequence and regulation of a gene encoding a human 89-kilodalton heat shock protein. Mol Cell Biol 9:2615-2626.
14. Johnson BD, Schumacher RJ, Ross ED, and Toft DO (1998) Hop modulates hsp70/ hsp90 interactions in protein folding. J Biol Chem 273:3679-3686.
15. Lai BT, Chin NW, Stanek AE, Keh W, and Lanks KW (1984) Quantitation and intracellular localization of the 85 K heat shock protein by using monoclonal and polyclonal antibodies. Mol Cell Biol 4:2802-2810.
16. Li T (2004) Alcohol use disorders and mood disorders: a National Institute on Alcohol Abuse and Alcoholism perspective. Biol Psychiatry 56:718-720.
17. Little RG and Petersen DR (1983) Subcellular distribution and kinetic parameters of HS mouse liver aldehyde dehydrogenase. Comp Biochem Physiol 74c:271-c279.
18. Luckey SW, Tjalkens RB, and Petersen DR (1999) Mechanism of inhibition of rat liver class 2 ALDH by 4-hydroxynonenal. Adv Exp Med Biol 463:71-77.
19. Minami M, Nakamura M, Emori Y, and Minami Y (2001) Both the N- and C-terminal chaperone sites of Hsp90 participate in protein refolding. Eur J Biochem 268:2520-2524.
20. Mitchell DY and Petersen DR (1991) Inhibition of rat hepatic mitochondrial aldehyde dehydrogenase-mediated acetaldehyde oxidation by trans-4-hydroxy-2-nonenal. Hepatology 13:728-734.
21. Nardai G, Sass B, Eber J, Orosz G, and Csermely P (2000) Reactive cysteines of the 90-kDa heat shock protein, Hsp90. Arch Biochem Biophys 384:59-67.
22. Niemela O (1999) Aldehyde-protein adducts in the liver as a result of ethanolinduced oxidative stress. Front Biosci 4:d506-513.
23. Oe T, Lee SH, Silva Elipe MV, Arison BH, and Blair IA (2003) A novel lipid hydroperoxide-derived modification to arginine. Chem Res Toxicol 16:1598-1605.
24. Perkins DN, Pappin DJ, Creasy DM, and Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551-3567.
25. Poli G and Schaur RJ (2000) 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50:315-321.
26. Raynes DA and Guerriero V Jr (1998) Inhibition of Hsp70 ATPase activity and protein renaturation by a novel Hsp70-binding protein. J Biol Chem 273:32883-32888.
27. Sampey BP, Korourian S, Ronis MJ, Badger TM, and Petersen DR (2003) Immunochemical characterization of hepatic malondialdehyde and 4-hydroxynonenanl modified proteins during early stages of ethanol-induced liver injury. Alcohol Clin Exp Res 27:1015-1023.
28. Shevchenko A, Wilm M, Vorm O, and MannM(1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850-858.
29. Solit DB, Scher HI, and Rosen N (2003) Hsp90 as a therapeutic target in prostate cancer. Semin Oncol 5:709-716.
30. Stinson F, Grant BF, and Dufour MC (2001) The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res 25:1181-1187.
31. Tsukamoto H and Lu S (2001) Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 15:1335-1349.
32. Uchida K and Stadtman ER (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase: a possible involvement of intra- and intermolecular cross-linking reaction. J Biol Chem 268:6388-6393.
33. Wegele H, Muller L, and Buchner J (2004) Hsp70 and Hsp90-a relay team for protein refolding. Rev Physiol Biochem Pharmacol 151:1-44.
34. Whitesell L, Shifrin SD, Schwab G, and Neckers LM (1992) Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition. Cancer Res 52:1721-1728.
35. Yamazaki M, Akaogi K, Miwa T, Imai T, Soeda E, and Yokoyama K (1989) Nucleotide sequence of a full-length cDNA for 90 kDa heat-shock protein from human peripheral lymphocytes. Nucleic Acids Res 17:7108.
36. Yonehara M, Minami Y, Kawata Y, Nagai J, and Yahara I (1996) Heat-induced chaperone activity of HSP90. J Biol Chem 271:2641-2645.